| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.3950 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.4372 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.4960 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.5237 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.5516 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.5979 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.5982 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6147 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6233 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6308 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6337 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6348 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6350 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6406 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6580 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.6840 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7032 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7132 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7279 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7353 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7405 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7508 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7547 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7899 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.7919 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8083 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8462 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8545 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8546 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8593 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8706 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8723 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8915 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8978 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.8995 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9015 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9084 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9164 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9198 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9214 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9322 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9455 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9466 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9608 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9625 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9790 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9868 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9923 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 0.9945 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0055 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0077 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0112 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0158 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0390 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0559 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0818 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0833 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.0991 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1032 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1240 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1286 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1305 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1447 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1591 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1599 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1605 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1646 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1721 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.1781 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2048 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2174 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2241 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2494 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2581 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2616 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2697 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.2929 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.3594 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.3617 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.4452 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.4548 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.4657 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.5151 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.5214 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.5707 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.5800 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.5846 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.6461 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.7174 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.7348 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.7699 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 1.9128 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 1.9653 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | adenosine | 1.9732 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | adenosine | 2.0117 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 2.1890 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 4.4942 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | adenosine | 5.7101 | scaled units | Low-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|